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Abstract 
Provision of pharmaceutical care services in community pharmacies is a new trend in pharmacy practice worldwide. Published 
literature from developed countries is available showing benefits of pharmaceutical care services provided in community pharmacies. 
However, relatively little published literature is available from developing countries in which unique market environments are 
encountered. This study was conducted to assess the acceptability of community pharmacy based pharmaceutical care services in 
Karachi. Pharmaceutical care services were developed and offered to pharmacy customers for a period of two months. Acceptability 
was evaluated with respect to enrollment of participants in the program, discontinuation, and complaints registered. The findings 
provide a better understanding of pharmaceutical care marketing strategies and are discussed within the context of the health care 
environment in Karachi. 
 
 
Introduction 
Pharmaceutical care is defined as “the responsible provision 
of drug therapy for the purpose of achieving definite 
outcomes that improve a patient’s quality of life”.
i
 Providing 
pharmaceutical care has become an integral part of pharmacy 
practice, irrespective of the setting. Community pharmacy 
plays a vital role in healthcare outcomes. Community 
pharmacists traditionally were engaged in the dispensing of 
medicine only. Over time, community pharmacists started 
offering pharmaceutical care services. A recent report from 
International Pharmaceutical Federation (FIP) has highlighted 
the role of pharmacists and community pharmacy for better 
healthcare services. It has also proposed guidelines for 
developing pharmacy practices.
ii
  
 
Research has been conducted in developed countries with 
respect to pharmaceutical care in community pharmacy and 
have shown the positive impact of pharmaceutical care 
services in different clinical settings. However, findings with 
respect to developing countries are still lacking.
iii
 No research 
was found with respect to community pharmacy based 
pharmaceutical care services in Pakistan. This study aims to 
assess the acceptability of pharmaceutical care services 
provided by community pharmacy among the residents of 
Karachi.   
 
Methods 
The study was conducted in an established community 
pharmacy with the approval of its owner. The pharmacy was 
located in a semi-developed area of Karachi. There were no 
other pharmacies within a five kilometer diameter of the 
study site. The area consists of a mixed population in term of 
race and education.   
 
 
 
A pharmaceutical care service was developed with the help of 
internet sources and a market survey. A final version of the 
pharmaceutical care services used in this study was made 
based upon the advice of experienced pharmacists and 
administrators. On arrival of a prescription, a trained 
pharmacist explained the services and its benefit to each 
pharmacy customer and invited him or her to enroll in the 
program. Upon accepting the invitation, a baseline form 
regarding demographic details was completed and then the 
prescription was prepared.  
 
Our primary objective was to describe enrollment, 
discontinuation, and complaints registered over a two month 
period. A complaint card was provided at the time of 
enrollment. Our secondary objective included a patient 
medication profile analysis of enrolled participants to 
describe diagnoses, number of drugs, and types of drugs used 
by enrollees.  
 
 Results 
Based on our market survey and advice of experienced 
pharmacists and administrators, we presented 
pharmaceutical care services as a bundled group of services. 
In our grouping strategy, we bundled services such as a 
discount policy, home delivery, and monitoring tests, which 
were familiar “value added” services to customers with new 
services such as medicine management, clinical pharmacist 
consultancy, and medication cards. In total, we grouped six 
services together (some familiar and some unfamiliar to 
customers) in a novel way that was new to this marketplace. 
The pharmaceutical care services offered during this study 
included six components: (1) medicine management, (2) 
customer medication card, (3) discount policy, (4) clinical 
pharmacist consultancy, (5) monitoring tests, and (6) home 
delivery. 
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Table 1: Pharmaceutical Care Services 
 
Medicine management Record of medications is 
maintained with regular 
review by pharmacist 
Home delivery Monthly supply to the 
address provided free of 
cost 
Medication card Card containing list of 
customer’s medications 
Discount policy Discount offered on 
monthly medication 
supply 
Clinical pharmacist 
consultancy 
A free consultancy will be 
provided to registered 
customer on regular basis 
to review their 
medication 
Monitoring Test Monitoring tests such as 
blood pressure measuring 
and glucose testing will 
be offered on regular 
basis 
 
The program “pharmaceutical care services” was offered over 
a two-month period during early 2011. During the study 
period, 350 customers visited the pharmacy in which 65 
customers bought only non-prescription (over-the-counter) 
drug products.  Amongst the 285 customers who purchased a 
prescription medication, 63 (22%) were enrolled into the 
services. The majority of those enrolled into the program 
were male (69%). The majority of these enrollees had 
multiple co-morbidities in which the most common co-
morbidities were dislipidemia (50%), hypertension (39%), and 
diabetes mellitus (31%).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Enrolled participants and their co-morbidities 
 
Enrolled Participants  
63 
22% 
Male  
44 
69% 
Dyslipidemia  
32 
50% 
Hypertension 
25 
39% 
Diabetes Mellitus 
20 
31% 
Depression 
7 
11% 
Ischemic Heart 
Disease 
6 
9% 
Asthma 
5 
8% 
Thyroid Disorder 
2 
2% 
Benign Prostatic 
Hyperplasia 
2 
2% 
Rheumatoid Arthritis 
1 
1% 
Epilepsy 
1 
1% 
 
 The total number of drugs prescribed for the 63 enrolled 
customers was 262 (average = 4.2 per enrollee). At the end of 
two months, no participants discontinued the program and 
two complaints were registered. Each of the complaints 
related to delays that were experienced in receiving 
medications. 
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Discussion 
The pharmacy profession is in a process of constant change.
iv
 
It has moved away from its traditional responsibility of 
supplying medicine towards a clinically-oriented, patient-
centered practice. 
v
 Thus, pharmacists are viewed less as a 
supplier of pharmaceutical products, and more as a provider 
of pharmaceutical care service.
vi
 Now the pharmacist’s task is 
to ensure that a patient’s drug therapy is appropriately 
indicated, and that the most effective, safe, and convenient 
ones are used by the patient. Pharmacists can contribute 
enormously in drug therapy outcome and patient’s quality of 
life by taking direct responsibility for patients’ drug related 
needs.
vii
 Over the years, pharmacists have been involved in 
providing evidence relating the abilities of pharmacists to 
address the needs of patients through successful integration 
of enhanced community practice models. The success of 
demonstrating the benefits of pharmacists has resulted in 
increased pressure for change and has led to the concept of 
pharmacists as providers of pharmaceutical care services.
viii
 
The provision of pharmaceutical care in community pharmacy 
is still in an evolutionary phase in different parts of world 
including Europe (Germany, Sweden), Canada and 
USA.
ix,x,xi,xii,xiii
 Such services sometimes are offered with a 
focus on a particular disease such as hyperlipidemia, coronary 
heart disease, asthma.
xiv-xv
  Economic evaluation of 
pharmacists involved in disease management in community 
pharmacy has shown to be beneficial in reducing monthly 
health costs in patients.
xvi
  
 
The concept of community pharmacy practice is not well 
developed in Pakistan; rather, a typical kind of practice can be 
best described as a “medical store”.
xvii
 Moreover, the 
proportion of pharmacy technicians or assistants in 
pharmaceutical selling facilities is quite high compared with 
the number of pharmacists.
xviii
 Often, medical stores are 
supervised by non-professional and unqualified personnel 
with limited knowledge of drugs.
xix
    
 
Putting Findings in Context: Pharmacy Practice in Karachi 
Karachi is the most populated city of Pakistan and has a 
competitive market. A market survey of different parts of 
Karachi revealed that numerous facilities for selling 
pharmaceutical products are operating in Karachi (see Table 
4). These facilities can be broadly classified into following: 
 
Institutional pharmacies: Institutional pharmacies are 
facilities that are affiliated with medical institutes such as 
hospitals, clinics, care homes etc. Most of these pharmacies 
are operated under the supervision of pharmacist and apply 
environmental and formulary controls. However, most 
pharmaceutical products disturbed through these pharmacies 
are for inpatients. Various services are offered by them such 
clinical pharmacy services and drug information but they are 
limited to the hospital. 
 
Community pharmacies: Like hospital pharmacies, they are 
operated under the supervision of a pharmacist and apply 
environmental controls. Typically, there are no 
pharmaceutical care services provided by community 
pharmacies. Instead, they tend to focus on convenient 
location and price competition. 
 
Large medical stores: A medical store is a place where 
pharmaceutical products and consumer products are sold by 
unqualified personnel mostly in unsuitable storage 
conditions. One of the most frequent offers that all types of 
medical stores provides is discounts, ranging from the five to 
ten percent. Convenient location to busy marketplaces also is 
a competitive strategy. 
 
Local medical stores: Like large medical stores, they offer 
discounts and convenient location to neighborhoods, but 
their inventory of pharmaceutical products is relatively low. 
To differentiate themselves from other stores, they may offer 
home delivery services. 
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Table 4 Market review of Karachi 
 
Type of 
Facility 
Services/ 
Advantages 
Differentiation Limitation 
Institutional 
pharmacy 
Clinical 
pharmacy, 
Drug 
information 
center,  
Parenteral 
nutrition 
preparation 
Clinical 
pharmacy, Drug 
information 
center, 
Parenteral 
nutrition 
preparation 
Limited to 
hospital 
inpatients 
Community 
pharmacy 
Pharmacist 
Discounts 
(typically 
5%) 
Environmen
tal controls 
 
Availability of 
Pharmacist 
No customer-
pharmacist 
relation due to 
managerial 
responsibilities 
Large 
Medical 
store 
5-10% 
Discounts 
Assurance 
of Product 
availability 
 
Assurance of 
Product 
availability  
No access to a 
pharmacist 
Local 
medical 
store 
Near home 
Home 
delivery 
Home delivery No access to a 
pharmacist 
 
In our study, we developed pharmaceutical care services in a 
competitive market environment. We expected a low 
enrollment rate for our project since the pharmaceutical care 
service offered suffered from a lack of awareness and the role 
of pharmacist as a medication adviser was novel to this 
market.
xx
 However, we propose that the idea of presenting 
pharmaceutical care as a group of services made the major 
difference in its acceptability. In our grouping strategy, we 
offered services such as a discount policy, home delivery, and 
monitoring tests, which were familiar “value added” services 
to customers. We then added new services that were new to 
customers such as medicine management, clinical pharmacist 
consultancy, and medication cards to the overall group of 
services. In total, we grouped six services together (some 
familiar and some unfamiliar to customers) in a novel way 
that was new to this marketplace.   
 
The findings revealed that the characteristics of enrolled 
participants tended to be educated, employed, and middle to 
old aged. Furthermore, it was also observed that most of the 
enrolled participants were suffering from multiple diseases 
and were using multiple  medications. Of the 63 enrolled 
customers, none discontinued the service and only two 
complaints were received over a two month period.  
 
Limitations 
This study had several limitations. First, we did not collect 
information from people who were offered the services, but 
did not enroll. Thus, there is no way compare those who 
enrolled with those who did not enroll. Second, the level of 
service provided in this study depended on the pharmacists 
working at the study pharmacy. Pharmacist competency may 
vary from pharmacy to pharmacy. Thus, extrapolation of our 
findings to other pharmacies is dependent upon pharmacist 
competency. Finally, we did not develop a business model for 
continuation of the pharmaceutical care services offered in 
this study. Our objective was to assess the acceptability of 
community pharmacy based pharmaceutical care services in 
Karachi. More work is needed to develop viable business 
models for these services.  
 
Conclusions 
The objective for this study was to assess the acceptability of 
community pharmacy based pharmaceutical care services in 
Karachi. The findings showed that 22 percent of pharmacy 
customers who were purchasing a prescription medication 
enrolled in the service when they were presented with an 
offer to enroll. Over a two-month period, none of the 
enrollees discontinued the service and the only two 
complaints that were registered, related to delays in receiving 
medications.  The findings provide a better understanding of 
pharmaceutical care marketing strategies and are discussed 
within the context of the health care environment in Karachi. 
Future research is needed to (1) describe clinical 
improvements in enrolled patients, (2) investigate 
perceptions of primary care physicians regarding such a 
program, and (3) develop viable business models for such 
service offerings in Karachi. 
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